
Gastroenterologist

No OPD information available
Colitis
Viral Gastroenteritis
Crohn's Disease
Hemorrhagic Proctocolitis
Ulcerative Colitis
Vitamin B12 Deficiency
Vitamin B12 Deficiency Anemia
Colonoscopy
Endoscopy
Malnutrition
Necrosis
Transcobalamin Deficiency
Viraj C. Kariyawasam is a male healthcare provider who helps people with various stomach and intestine problems like colitis, viral gastroenteritis, Crohn's disease, hemorrhagic proctocolitis, ulcerative colitis, and vitamin B12 deficiency. He performs procedures like colonoscopy and endoscopy to diagnose and treat these conditions. He also helps patients with malnutrition and other issues related to the digestive system.
Viraj C. Kariyawasam is good at talking to patients and making them feel comfortable. Patients trust him because he listens carefully to their concerns and explains things in a way they can understand. He is kind and caring, which helps patients feel safe and supported during their treatment.
To make sure he provides the best care, Viraj C. Kariyawasam stays up-to-date with the latest medical knowledge and research. This helps him offer the most effective treatments to his patients. He also works closely with other healthcare professionals to coordinate care and provide comprehensive treatment plans.
Viraj C. Kariyawasam's work has positively impacted many patients' lives. His treatments have helped people feel better and improve their health. He has also contributed to medical research by publishing articles in journals and participating in clinical trials to advance knowledge in the field of gastroenterology.
One of his notable publications is a comment on the effectiveness of early thiopurine use in patients with ulcerative colitis. He has also been involved in clinical trials comparing gastrointestinal transit measurements in patients with gastroparesis and slow transit constipation.
Overall, Viraj C. Kariyawasam is a dedicated healthcare provider who uses his expertise and compassion to help patients with digestive issues lead healthier lives.
Enrollment Status: Completed
Published: July 20, 2023
Intervention Type: Device
Study Drug:
Study Phase: Not Applicable
